Publications in collaboration with researchers from Utrecht University (7)

2024

  1. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2020

  1. Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC study

    Journal of Veterinary Internal Medicine, Vol. 34, Núm. 3, pp. 1108-1118

2018

  1. Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC Study

    Journal of Veterinary Internal Medicine, Vol. 32, Núm. 1, pp. 72-85

2017

  1. Die Wirkung von Pimobendan bei Hunden mit praklinischer myxomatoser Mitralklappen- erkrankung und Kardiomegalie: Die EPIC-Studie - Eine randomisierte klinische Studie

    Kleintierpraxis, Vol. 62, Núm. 2, pp. 64-87

2016

  1. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study—A Randomized Clinical Trial

    Journal of Veterinary Internal Medicine, Vol. 30, Núm. 6, pp. 1765-1779

2014

  1. Comparison of serum amyloid A and C-reactive protein as diagnostic markers of systemic inflammation in dogs

    Canadian Veterinary Journal, Vol. 55, Núm. 2, pp. 161-168

2013

  1. Canine serum amyloid A (SAA) measured by automated latex agglutination turbidimetry is useful for routine sensitive and specific detection of systemic inflammation in a general clinical setting

    Journal of Veterinary Medical Science, Vol. 75, Núm. 4, pp. 459-466